Scholarship 11/19758-5 - Oncologia, Análise de sequência com séries de oligonucleotídeos - BV FAPESP
Advanced search
Start date
Betweenand

Genetic profile analysis of tumor stem cells in locally advanced breast cancer

Grant number: 11/19758-5
Support Opportunities:Scholarships in Brazil - Doctorate
Start date until: February 01, 2012
End date until: September 30, 2015
Field of knowledge:Health Sciences - Medicine
Principal Investigator:Helio Humberto Angotti Carrara
Grantee:Willian Abraham da Silveira
Host Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Associated scholarship(s):13/24757-3 - Genetic profile analysis of tumor stem cells in locally advanced breast cancer, BE.EP.DR

Abstract

Breast carcinoma is a highly prevalent and incident disease. About half the cases we normally find receive the diagnostic in later and/or disseminated stages. The rate of success in such cases are small. The neoadjuvant chemotherapy have been used like a initial treatment for these patients. We know that the great benefit of the citotoxic treatment is achieved by patiets with complete pathologic response to neoadjuvant chemotherapy. This patient´s group represents about 20% of the cases. Identify previously a patient´s group who would most benefit from neoadjunvant therapy can reduce treatment costs and avoid adverse effects in patients with low probability of response. However, is not yet possible to make such a prediction, even with the use of advanced molecular biology. Breast carcinoma is a highly prevalent and incident disease. About half the cases we normally find receive the diagnostic in later and/or disseminated stages. The rate of success in such cases are small. The neoadjuvant chemotherapy have been used like a initial treatment for these patients. We know that the great benefit of the citotoxic treatment is achieved by patiets with complete pathologic response to neoadjuvant chemotherapy. This patient´s group represents about 20% of the cases. Identify previously a patient´s group who would most benefit from neoadjunvant therapy can reduce treatment costs and avoid adverse effects in patients with low probability of response. However, is not yet possible to make such a prediction, even with the use of advanced molecular biology. Recently in the literature, relates about cancer stem cells be the responsible for tumor recurrence. This celular sub-population have the capacity to repopulate the hostage with cancer cells with the same origin. It is also postulated that this cell subpopulation is resistant to radiotherapy and chemotherapy. Thus, the prognosis of a patient directly depend on the amount or quality of CSCs present in their tumor at the time of treatment. Identify, characterize and quantify the presence of CSCs in the primary tumor can be an effective method of predicting response to neoadjuvant chemotherapy in locally advanced breast cancer. The objetive of this study evaluate the quantity, estimated by flow citometry, and the genetic profile os CSCs (isolated by FACS) in the primary tumor before the and correlate them with pathological response to the treatment regimen employed.

News published in Agência FAPESP Newsletter about the scholarship:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
DA SILVEIRA, W. A.; PALMA, P. V. B.; SICCHIERI, R. D.; VILLACIS, R. A. R.; MANDARANO, L. R. M.; OLIVEIRA, T. M. G.; ANTONIO, H. M. R.; ANDRADE, J. M.; MUGLIA, V. F.; ROGATTO, S. R.; et al. Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype. SCIENTIFIC REPORTS, v. 7, . (11/19758-5)

Please report errors in scientific publications list using this form.